LFG
BBNX

Larson Financial Group’s Beta Bionics BBNX Stock Holding History

Larson Financial Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.43K Sell
538
-19
-3% -$226 ﹤0.01% 2516
2026
Q1 		$5.58K Buy
557
+280
+101% +$4.14K ﹤0.01% 2545
2025
Q4 		$8.44K Buy
+277
New +$7.4K ﹤0.01% 2214

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Larson Financial Group's BBNX Position: Q2 2026 in Review

Larson Financial Group reduced its Beta Bionics (BBNX) stake by 3.4% in Q2 2026, selling an estimated $226 and leaving 538 shares worth $8.43K. The position accounts for ﹤0.01% of the portfolio, ranked #2516.

Larson Financial Group first reported a position in BBNX in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.44K in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Larson Financial Group held 538 shares of Beta Bionics worth $8.43K as of Q2 2026.
  • Larson Financial Group sold 19 Beta Bionics shares in Q2 2026, an estimated $226.
  • Beta Bionics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2516 holding.
  • Larson Financial Group first reported a position in Beta Bionics in Q4 2025 and has held it in 3 quarters since.
  • Larson Financial Group's Beta Bionics position peaked at $8.44K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.